Cargando…
Total and Component Health Care Costs in a Non-Medicare HMO Population of Patients With and Without Type 2 Diabetes and With and Without Macrovascular Disease
BACKGROUND: Type 2 diabetes (T2DM) is one of the most prevalent and costly chronic conditions in the United States. Macrovascular disease (MVD) remains a common and costly comorbidity in T2DM. Understanding the impact of MVD on total health care costs in patients with T2DM is of great importance to...
Autores principales: | Gandra, Shravanthi R., Lawrence, Lesa W., Parasuraman, Bhash M., Darin, Robert M., Sherman, Justin J., Wall, Jerry L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437776/ https://www.ncbi.nlm.nih.gov/pubmed/16981800 http://dx.doi.org/10.18553/jmcp.2006.12.7.546 |
Ejemplares similares
-
Cost and Outcomes of Medicare Reimbursement for HMO Preventive Services
por: Patrick, Donald L., et al.
Publicado: (1999) -
An outlier pool for Medicare HMO payments
por: Beebe, James C.
Publicado: (1992) -
Impact of HMO Withdrawals on Vulnerable Medicare Beneficiaries
por: Schoenman, Julie A., et al.
Publicado: (2005) -
Health Care Use and Expenditures of Medicare HMO Disenrollees
por: Parente, Stephen T., et al.
Publicado: (2005) -
MCBS Highlights: Comparison of Medicare Risk HMO and FFS Enrollees
por: Murgolo, Maggie S.
Publicado: (2002)